Drug information for TRIBENZOR
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
EQ 10MG BASE;12.5MG;40MG
Prescription
AMLODIPINE BESYLATE
;
HYDROCHLOROTHIAZIDE
;
OLMESARTAN MEDOXOMIL
Tribenzor
DAIICHI SANKYO
200175
2012-01-23 Label
2012-01-23 Letter
2011-11-04 Label
2011-11-03 Letter
2011-07-15 Review
2011-07-15 Summary Review
2011-06-29 Label
2011-06-27 Letter
2011-04-11 Label
2011-04-06 Letter
2010-07-30 Label
2010-07-28 Letter
TABLET; ORAL
EQ 10MG BASE;25MG;40MG
Prescription
(Reference Drug)
AMLODIPINE BESYLATE
;
HYDROCHLOROTHIAZIDE
;
OLMESARTAN MEDOXOMIL
Tribenzor
DAIICHI SANKYO
"
TABLET; ORAL
EQ 5MG BASE;12.5MG;20MG
Prescription
AMLODIPINE BESYLATE
;
HYDROCHLOROTHIAZIDE
;
OLMESARTAN MEDOXOMIL
Tribenzor
DAIICHI SANKYO
"
TABLET; ORAL
EQ 5MG BASE;12.5MG;40MG
Prescription
AMLODIPINE BESYLATE
;
HYDROCHLOROTHIAZIDE
;
OLMESARTAN MEDOXOMIL
Tribenzor
DAIICHI SANKYO
"
TABLET; ORAL
EQ 5MG BASE;25MG;40MG
Prescription
AMLODIPINE BESYLATE
;
HYDROCHLOROTHIAZIDE
;
OLMESARTAN MEDOXOMIL
Tribenzor
DAIICHI SANKYO
"
Drug Adverse Effects information for TRIBENZOR
Role code
Indications
Reaction
# Reports
PS
HYPERTENSION
BLINDNESS UNILATERAL
1
C
ATRIAL FIBRILLATION
BLOOD THYROID STIMULATING HORMONE DECREASED
1
C
ATRIAL FIBRILLATION
DYSPEPSIA
1
C
BLOOD PRESSURE ABNORMAL
ORAL DISCOMFORT
1
C
BLOOD PRESSURE ABNORMAL
OROPHARYNGEAL BLISTERING
1
C
HYPERTENSION
BLOOD THYROID STIMULATING HORMONE DECREASED
2
C
HYPERTENSION
DYSPEPSIA
2
C
HYPOTHYROIDISM
BLOOD THYROID STIMULATING HORMONE DECREASED
1
C
HYPOTHYROIDISM
DYSPEPSIA
1
C
MULTIPLE SCLEROSIS
ACUTE RESPIRATORY FAILURE
1
C
MULTIPLE SCLEROSIS
CENTRAL NERVOUS SYSTEM LYMPHOMA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ACUTE RESPIRATORY FAILURE
5
C
PRODUCT USED FOR UNKNOWN INDICATION
CENTRAL NERVOUS SYSTEM LYMPHOMA
5
C
PROSTATOMEGALY
BLOOD THYROID STIMULATING HORMONE DECREASED
1
C
PROSTATOMEGALY
DYSPEPSIA
1
C
SMOKING CESSATION THERAPY
ORAL DISCOMFORT
1
C
SMOKING CESSATION THERAPY
OROPHARYNGEAL BLISTERING
1
Ads by Google